Impax Laboratories Inc (NASDAQ:IPXL)

46.31
Delayed Data
As of Jul 02
 -0.34 / -0.73%
Today’s Change
22.12
Today|||52-Week Range
52.10
+46.18%
Year-to-Date
No recent news for Impax Laboratories Inc.

Today’s Trading

Previous close46.65
Today’s open46.78
Day’s range45.90 - 46.97
Volume572,203
Average volume (3 months)782,697
Market cap$3.3B
Dividend yield--
Data as of 3:59pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)-44.90%
Earnings growth (this year)+6.92%
Earnings growth (next 5 years)+23.50%
Revenue growth (last year)+16.53%
P/E ratio73.0
Price/Sales3.75
Price/Book3.72

Competitors

 Today’s
change
Today’s
% change
ANACAnacor Pharmaceutica...-1.20-1.50%
PBYIPuma Biotechnology I...-0.15-0.13%
WXWuXi PharmaTech (Cay...-0.17-0.40%
CBPOChina Biologic Produ...+1.98+1.75%
Data as of 4:02pm ET, 07/02/2015

Financials

Next reporting dateAugust 4, 2015
EPS forecast (this quarter)$0.38
Annual revenue (last year)$596.0M
Annual profit (last year)$57.4M
Net profit margin9.62%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
George Frederick Wilkinson
Senior Vice President-
Global Operations
Andrew Schaschl
Corporate headquarters
Hayward, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers